Purchase Order 36C25623P0635

Award Date 3/31/23
Potential Completion Date 12/31/23
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price purchase order to Sirtex Medical Inc., a global healthcare company, to provide microspheres containing Yttrium-90 for $170,000.00. These specialized radioactive microspheres are used in selective internal radiation therapy to treat liver tumors and metastatic disease for veterans. The contract has no set-aside designation. Through the supply of these niche cancer therapies, Sirtex Medical supports VA...
The Defense Health Agency (DHA) awarded a $177,500.00 firm fixed price purchase order to Sirtex Medical Inc., a for-profit global healthcare company, to provide ten selective internal radiation resin microspheres for the Radiology Department at Walter Reed National Military Medical Center. The microspheres, containing Yttrium-90, are used in selective internal radiation therapy to treat liver tumors and metastatic disease in veterans and military members. This contract award has no set-aside...
This firm fixed-price purchase order was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense (DOD) to Sirtex Medical Inc., a global healthcare company, to provide SIR-Spheres Y-90 resin microspheres. These radioactive microspheres are used in selective internal radiation therapy (SIRT) to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. The contract has a ceiling value of...
This firm-fixed-price purchase order, valued at $171,659.00, was awarded by the U.S. Department of Veterans Affairs (VA) to Sirtex Medical Inc. for the delivery of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy used to treat liver tumors, as well as associated delivery equipment. The contract, which has an ultimate completion date of September 30, 2025, was awarded on October 1, 2024 and does not have a set-aside designation. Sirtex Medical Inc. is a global healthcare...
The Department of the Army Medical Command awarded a firm fixed price BPA call contract to Sirtex Medical Inc., a for-profit medical device company, to supply SIR-SPHERES Y-90 resin microspheres. These specialized radioactive microspheres are used in selective internal radiation therapy to treat inoperable liver cancer in veterans and military members. The contract has a potential value of $144,000.00 and a completion date of April 30, 2017. No set-aside designation was used for this award....
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a for-profit organization headquartered in Woburn, Massachusetts. The contract is for the supply of Y-90 resin microspheres, a specialized radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract has a ceiling value of $138,400.00 and a completion date of May 25, 2022. The contract is not designated as a set-aside. Sirtex Medical Inc. has a...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Sirtex Medical Inc., a global healthcare company that provides medical devices and therapies for cancer treatment. The contract is for the supply of 2 doses of Yttrium-90 (Y-90) base period plus one option period with 8 additional doses, for a potential total value of $156,735.00. The Y-90 resin microspheres, branded as Sir-Spheres, are used in selective internal radiation...
This firm-fixed-price purchase order was awarded to Sirtex Medical Inc., a for-profit medical device company, by the Defense Health Agency. The contract is for the supply of SIR-Spheres Y-90 radioactive microspheres, which are used in interventional radiology procedures to treat liver tumors and metastatic disease through internal radiation therapy. The contract has a potential value of $17,750.00 and a completion date of August 1, 2022. The contract does not have a set-aside designation. Sirtex...
This federal contract award to Sirtex Medical Inc. is for the delivery of SIR-Spheres Y-90 resin microspheres, a medical device used in selective internal radiation therapy to treat inoperable liver cancer. The contract, awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $416,000.00. Sirtex Medical, a global healthcare company, is the prime contractor supplying these specialized radioactive spheres to the VA and DOD healthcare systems. The...
The Department of Veterans Affairs Veterans Health Administration awarded a $148,500 firm-fixed-price purchase order to Sirtex Medical Inc. on September 7, 2018 to provide Sir-Spheres Y-90 resin microspheres for use in selective internal radiation therapy at VA medical centers. This award had no set-aside designation. Sirtex Medical, a global healthcare company, is the prime contractor providing these specialized radioactive microspheres that are used to treat inoperable liver cancer in...

This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Sirtex Medical Inc., a global healthcare company, to provide RESIN Y-90 MICROSPHERES with a potential value of $17,300.00. The microspheres, which contain the radioactive isotope Yttrium-90, are used in selective internal radiation therapy to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. The contract has no set-aside designation. Sirtex Medical has previously been awarded similar contracts by the VA, Department of Defense, Army Medical Command, and Defense Health Agency to supply these specialized radioactive microspheres and associated medical devices for the treatment of cancer in the federal healthcare system.

Generated 6/5/24, 10:15 AM